Login / Signup

Mepolizumab failed to affect bullous pemphigoid: A randomized, placebo-controlled, double-blind phase 2 pilot study.

Dagmar SimonShida YousefiSimone CazzanigaChristina BürglerSusanne RadonjicCarine HourietKristine HeidemeyerHans-Wilhelm KlötgenEvelyne KozlowskiLuca BorradoriHans-Uwe Simon
Published in: Allergy (2019)
Keyphrases
  • placebo controlled
  • double blind
  • phase iii
  • clinical trial
  • phase ii
  • study protocol
  • phase ii study
  • radiation therapy
  • open label